Reprint

Antimicrobial Use across Different Healthcare Settings, Countries and Specific Populations

Edited by
August 2024
134 pages
  • ISBN978-3-7258-1534-0 (Hardback)
  • ISBN978-3-7258-1533-3 (PDF)

This is a Reprint of the Special Issue Antimicrobial Use across Different Healthcare Settings, Countries and Specific Populations that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

Antimicrobial use is one of the main drivers of antimicrobial resistance (AMR), a crisis threatening modern medicine. To combat and reverse AMR, finding determinants of resistance development/antibiotic use, identifying the target points of interventions, and implementing antibiotic stewardship measures are crucial.

This Special Issue disseminates a wide variety of research conducted by various study designs and diverse settings and populations. It includes studies:

  • Focusing on the role of antibiotics/antibacterials on specific diseases;
  • Reporting the effect of antibiotic stewardship interventions on different outcomes;
  • Describing the quality of prophylactic antibiotic use in a patient-specific population;
  • Identifying determinants of antibiotic use in the elderly or resistance development in specific bacteria;
  • Introducing a novel reporting tool for auditing antibiotic dispensing practice.
Format
  • Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
community acquired pneumonia; hospitalized patients; empirical antibiotic therapy; guideline adherence; clinical outcomes; 30-day mortality; CRP on admission; CCI score; global health; antimicrobial stewardship; COVID-19; disaster planning; drug resistance; bacterial; antimicrobial resistance; anti-bacterial agents; primary care; Escherichia coli; quinolones; fluoroquinolones; information storage and retrieval; adolescents; antibiotics; children; COVID-19; claims data; Germany; prescription rates; SARS-CoV-2; community pharmacy practice; dispensing quality; antibiotics; antimicrobial resistance; Audit Project Odense; paediatric liver transplantation; perioperative prophylaxis; antibiotics; antibiotic exposure; antimicrobials; infectious disease specialist; infection surveillance; infection prevention; antibiotic misuse; older adults; Theory of Planned Behaviour; antimicrobial resistance; antibiotic stewardship; COVID-19; antimicrobial stewardship; antibiotic consumption; ceftobiprole; sepsis; older; real-world data; OPAT; Crohn’s disease; Escherichia coli; Mycobacterium avium paratuberculosis; antibiotic therapy